Literature DB >> 3583698

Pneumococcal bacteremia--no change in mortality in 30 years: analysis of 104 cases and review of the literature.

M R Kramer, B Rudensky, I Hadas-Halperin, M Isacsohn, E Melzer.   

Abstract

We evaluated 104 cases of pneumococcal bacteremia retrospectively: 55 adults and 49 children. The overall mortality rate was 33% in adults, and 6% in children. Mortality was associated with old age, severe underlying disease, vague clinical presentation, multilobar pneumonia, leukopenia and metabolic acidosis. Both vigorous treatment with mechanical ventilation devices, vasopressors and steroids, and sophisticated monitoring in the Intensive Care Unit did not improve survival. In six cases (5.8%) the pneumococcus was resistant to penicillin G. In reviewing the literature of the last 30 years, no change in mortality rate was noted. Vaccination of population at risk is highly recommended.

Entities:  

Mesh:

Year:  1987        PMID: 3583698

Source DB:  PubMed          Journal:  Isr J Med Sci        ISSN: 0021-2180


  22 in total

1.  Pneumolysin-induced complement depletion during experimental pneumococcal bacteremia.

Authors:  R B Alcantara; L C Preheim; M J Gentry-Nielsen
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

2.  Clinical presentation, processes and outcomes of care for patients with pneumococcal pneumonia.

Authors:  J A Brandenburg; T J Marrie; C M Coley; D E Singer; D S Obrosky; W N Kapoor; M J Fine
Journal:  J Gen Intern Med       Date:  2000-09       Impact factor: 5.128

Review 3.  The pneumococcal problem.

Authors:  S K Obaro; M A Monteil; D C Henderson
Journal:  BMJ       Date:  1996-06-15

4.  Role of gamma interferon in the pathogenesis of bacteremic pneumococcal pneumonia.

Authors:  J B Rubins; C Pomeroy
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

5.  Comprehensiveness and bias in reporting clinical trials. Study of reviews of pneumococcal vaccine effectiveness.

Authors:  B G Hutchison; A D Oxman; S Lloyd
Journal:  Can Fam Physician       Date:  1995-08       Impact factor: 3.275

6.  The pneumococcus: host-organism interactions and their implications for immunotherapy and immunoprophylaxis.

Authors:  F E Perry; J R Catterall
Journal:  Thorax       Date:  1994-10       Impact factor: 9.139

7.  Oropharyngeal colonization by Streptococcus pneumoniae among HIV-infected adults in Uganda: assessing prevalence and antimicrobial susceptibility.

Authors:  David B Blossom; Grace Namayanja-Kaye; Joan Nankya-Mutyoba; John B Mukasa; Henry Bakka; Sandra Rwambuya; Anne Windau; Saralee Bajaksouzian; Courtney J Walker; Moses L Joloba; Cissy Kityo; Peter Mugyenyi; Christopher C Whalen; Michael R Jacobs; Robert A Salata
Journal:  Int J Infect Dis       Date:  2006-09-25       Impact factor: 3.623

8.  Pharmacodynamic modeling of clarithromycin against macrolide-resistant [PCR-positive mef(A) or erm(B)] Streptococcus pneumoniae simulating clinically achievable serum and epithelial lining fluid free-drug concentrations.

Authors:  Ayman M Noreddin; Danielle Roberts; Kim Nichol; Aleksandra Wierzbowski; Daryl J Hoban; George G Zhanel
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

9.  Identification of hydrogen peroxide as a Streptococcus pneumoniae toxin for rat alveolar epithelial cells.

Authors:  P G Duane; J B Rubins; H R Weisel; E N Janoff
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

10.  Toxicity of pneumolysin to pulmonary alveolar epithelial cells.

Authors:  J B Rubins; P G Duane; D Clawson; D Charboneau; J Young; D E Niewoehner
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.